Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2025-12-24 @ 12:21 PM
NCT ID:
NCT06549361
Eligibility Criteria:
Inclusion Criteria:
* 1\. ≥ 18 years (including 18 years).
* 2\. Pathologically diagnosed with diffuse large B-cell lymphoma according to the 2016 WHO classification, including non-specific types and various special subtypes.
* 3\. Newly diagnosed DLBCL with involvement of extranodal organs.
* 4\. Patients who have received clinical treatment for lymphoma.
* 5.Patients with measurable lesions, including at least one effective efficacy assessment.
Exclusion Criteria:
* 1\. Patients receiving supportive care only.
* 2\. Patients who cannot obtain effective efficacy assessment data.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06549361
Study Brief:
Protocol Section:
NCT06549361